I work at amgen. ask me anthing. I'll answer honestly

Definitely doesn't look good for gbu neph reps and referral reps. I heard some of our marketing have been told they will offer relocation packages if they don't keep the home office open. Initial plan is keeping it as part of amgens expansion into rare disease.

 

Our insurance here isn’t that great. Our cost is on the higher end ($500+ a month for a family). Do you have to pay a monthly stipend for the car on top of mileage (sorry if I missed that already)? Multiple companies charge that now. I’m looking forward to a company vehicle again. Our allowance situation is total crap here. After taxes you’re looking at maybe $600, and all they pay for is gas. We don’t even get paid for mileage! If you have a geography with multiple large states, you really get screwed unless you fly a lot, which has been a pain in the ass over the last year and a half.

If they keep our at target bonus dollar amount the same or close to it, this may not be THAT bad for most of us in the field that get to keep our jobs. There are already changes coming in IC that will minimize the crazy big bonuses anyway,

 

Not true Horizon will pay out even larger bonuses in q1

 

IC is capped at Amgen in two ways. First, it is set by your job level. Most will come in at ACT 2. IC goal will be in the 40k range with a cap at doubling (to 80k). I don’t think they lower salaries. Scroll back. Cars has been covered in detail.

 

will we get in trouble or promoted if we leave the water on the bathtub and flood our hotel room while having relations with a co worker at the NSM? Just asking for a friend.

 

Promotions or punishment is determined by your selected and projected pronouns. Choose wisely before engaging in any risky activities

 

Does Amgen promote hotties to DM positions? If yes, where are they located?

 

Maybe you’re in a different BU, but not in the GBU. Ask anyone on the IC team. It’s the same target bonus - same budget, but less variance in pay out…especially neph…no more milestone payout & 50% pay on vials (unless they change it again).

 

Hmmm, I guess we will see what they do for rare disease in terms of IC. You seem to keep assuming that rare disease will be treated the same as non-rare disease. Typically bonus target is higher with rare. That’s standard for even bigger companies like Novartis. I know that they let Chemocentryx keep their base salary. I did not ask the rep about IC.

 

(I’m the OP) This is still being discussed. I’ll keep you informed as things progress.

 

Horizon’s is $496/mo just for medical. I doubt it’s $800/mo at Amgen!

 

\

I'm on the IC team...more $ for payouts. Yes less variance which means more money for more people. Not on the IC calls for Neph...they should be looking for jobs. Not looking good for them in any scenario.

Also 50% pay on vials isn't happening at all on the Rheum side.

 

not sure how many times Horizon people can explain to you that vial reporting is not tied to doctor. It’s tied to infusion site Yes, we have enrollment forms, too, but they don’t always get used. There’s more complexities than pills/self-injectables. You do not know how they will choose to define credit, but at most companies it’s based on where the infusion occurred.
Also, we have HUGE geographies. If we cover the university, then we cover the rural area.
There’s a more complex situation with the GBU and referrals. It will be interesting to see how Amgen handles it. It’s very weird. I can’t imagine that it won’t change.

 

Every single employee has a capped IC. Not sure why you’d think rare disease would be different from oncology. I expect the two units to be treated the same.

 

1) this started with you or another person saying I was incorrect about the crazy big bonuses coming to an end (as you agree, less variance). So, yes, I WAS correct.
2) It’s still not MORE money FOR payouts for Q1. Same amount of money in budget, Different dispersement.
3) I do agree that NSAMs should worry about their jobs. I can see Amgen making rheum territories a little smaller and then having the rep call on all specialties. They like small geographies…always had much smaller geographies in rheum than competitors. I bet rheum reps will eventually be realigned no matter what. At least some definitely do not have the same opportunity based on number of doctors and claims (though they are supposed to).. I know for a fact that JH gave special treatment to certain people.

 

Don’t know where you’re getting that I don’t think that it would be capped. Saying that the at target (100%) amount would likely be higher than Enbrel reps. Ours is currently $64k. I also would not EXPECT Oncology to be the same. I depends on what Oncology gets paid. Plus, at another big pharma company that has onc, rare disease, and standard specialty, and the rare disease team gets paid more in base and IC. The rare disease roles are a higher band/pay grade. I guess we will see.

 

This right here is too funny

 

Amgen doesn't even know. They aren't going to give y'all special treatment. You will be treated like micromanaged children here. Every division is expected to abide by their rules. You aren't getting higher bonuses. And your salaries will be kept. They don't pay high salaries here so keeping you at your high bases may not work out in the long run if you know what I mean.

 

Most of our marketing personnel came from these companies and were not on the top of food chain for creativity and smarts. Sorry but transparency is a must.

 

(I’m the OP) Everyone calm down! When I know more then I’ll relay the info to you all